Experimental Biology And Medicine | Finanzwire

Basculer en Français

10820	Companies
234662	Keywords
163523	Articles
125584	Press releases

Headlines Articles Press releases Experimental Biology And Medicine

Home
Companies
Experimental Biology And Medicine

BRIEF

published on 06/18/2024 at 15:05, 2 years 1 month ago

New Study Examines How Topical Naltrexone Restores Tear Production in Diabetic Dry Eye

Diabetic Dry Eye Naltrexone Tear Production OGF-OGFr Pathway Ocular Complications
PRESS RELEASE

published on 06/18/2024 at 15:00, 2 years 1 month ago

New Study Examines How Topical Naltrexone Restores Tear Production in Diabetic Dry Eye
Study led by Dr. Pat McLaughlin reveals topical naltrexone's effectiveness in reversing dry eye in diabetic rats. Findings point to OGF-OGFr pathway blockade as a promising treatment approach

Diabetes Experimental Biology And Medicine Naltrexone OGF-OGFr Pathway Dry Eye
BRIEF

published on 04/03/2024 at 15:05, 2 years 4 months ago

HTERT Vaccine Shows Promise in Therapy-Resistant Cancer Patients, Study Finds

Cancer Immunotherapy HTERT Vaccination Therapy-resistant Cancer Immune Response King's College London
PRESS RELEASE

published on 04/03/2024 at 15:00, 2 years 4 months ago

Study Shows hTERT Vaccination Induces Immunological Responses and Prevents Progression in a Subset of Therapy-Resistant Poor Prognosis Cancer Patients
A Phase 1 clinical trial led by James Spicer at King's College London showcases promising developments in immune therapy for solid tumours via hTERT vaccination. Published in Experimental Biology and Medicine

Solid Tumors Clinical Trial HTERT Vaccination Immune Therapy Experimental Biology And Medicine

Accesswire

Published on 08/12/2026 at 00:00, 7 hours 22 minutes ago

Organto Foods Reports Record Second Quarter 2026 Financial Results
Published on 08/11/2026 at 23:40, 7 hours 42 minutes ago

RJK Explorations Ltd. Announces Private Placement for Gross Proceeds of up to $100,000
Published on 08/11/2026 at 23:15, 8 hours 7 minutes ago

Fermi and Hillcore Energy Capital Announce 2.6 Gigawatt Power Strategic Alliance for Project Matador
Published on 08/11/2026 at 23:00, 8 hours 22 minutes ago

Prospectiva Resources Ltd. Completes Qualifying Transaction
Published on 08/11/2026 at 22:55, 8 hours 27 minutes ago

NV Gold Announces Non-Brokered Private Placement

View all ACCESSWIRE

EQS Group

Published on 08/12/2026 at 07:10, 12 minutes ago

Deutsche Konsum Real Estate AG publishes quarterly statement for the first nine months of the 2025/2026 financial year
Published on 08/12/2026 at 07:00, 22 minutes ago

MindMaze Therapeutics Appoints Prof. John W. Krakauer as Strategic Advisor
Published on 08/12/2026 at 07:00, 22 minutes ago

SCHOTT Pharma with strong third quarter and on track for planned growth
Published on 08/12/2026 at 07:00, 22 minutes ago

TUI delivered resilient Q3 underlying EBIT of €234.6m (at CC), demonstrating the strength of its business despite geopolitical headwinds and one-offs, FY26 guidance reaffirmed
Published on 08/12/2026 at 07:00, 22 minutes ago

E.ON remains on track and continues to invest in the energy transition

Les Echos

Published on 08/10/2026 at 18:00, 1 day 13 hours ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 17:45, 1 day 13 hours ago

Weekly share buyback
Published on 08/10/2026 at 11:53, 1 day 19 hours ago

GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Published on 08/10/2026 at 11:36, 1 day 19 hours ago

GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
Published on 08/10/2026 at 09:22, 1 day 22 hours ago

Number of shares and voting rights - July 2026 (In French only)

View all LES ECHOS COMFI WIRE